Overview

Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Using repeated arthroscopic biopsies of patients with rheumatoid arthritis, the researchers will assess changes in the immune response that occur as a result of treatment with rituximab.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Diego
Collaborator:
Genentech, Inc.
Treatments:
Rituximab